Literature DB >> 20838906

Tumor hypoxia imaging.

Xilin Sun1,2, Gang Niu3,4, Nicholas Chan1, Baozhong Shen2, Xiaoyuan Chen5.   

Abstract

There is a need to measure tumor hypoxia in assessing the aggressiveness of tumor and predicting the outcome of therapy. A number of invasive and noninvasive techniques have been exploited to measure tumor hypoxia, including polarographic needle electrodes, immunohistochemical staining, radionuclide imaging (positron emission tomography [PET] and single-photon emission computed tomography [SPECT]), magnetic resonance imaging (MRI), optical imaging (bioluminescence and fluorescence), and so on. This review article summarizes and discusses the pros and cons of each currently available method for measuring tissue oxygenation. Special emphasis was placed on noninvasive imaging hypoxia with emerging new agents and new imaging technologies to detect the molecular events that are relevant to tumor hypoxia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20838906     DOI: 10.1007/s11307-010-0420-z

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  143 in total

1.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Authors:  Y Fujibayashi; H Taniuchi; Y Yonekura; H Ohtani; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

Review 2.  19F: a versatile reporter for non-invasive physiology and pharmacology using magnetic resonance.

Authors:  Jian-xin Yu; Vikram D Kodibagkar; Weina Cui; Ralph P Mason
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.

Authors:  S Hunjan; D Zhao; A Constantinescu; E W Hahn; P P Antich; R P Mason
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

Review 4.  Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.

Authors:  Johanna Westra; Grietje Molema; C G M Kallenberg
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

Authors:  J A Raleigh; D P Calkins-Adams; L H Rinker; C A Ballenger; M C Weissler; W C Fowler; D B Novotny; M A Varia
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

Review 6.  Non-invasive PET and SPECT imaging of tissue hypoxia using isotopically labeled 2-nitroimidazoles.

Authors:  Cameron J Koch; Sydney M Evans
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

7.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

8.  Dendritic phosphorescent probes for oxygen imaging in biological systems.

Authors:  Artem Y Lebedev; Andrei V Cheprakov; Sava Sakadzić; David A Boas; David F Wilson; Sergei A Vinogradov
Journal:  ACS Appl Mater Interfaces       Date:  2009-06       Impact factor: 9.229

9.  The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response.

Authors:  Maud H W Starmans; Daniel Zips; Bradly G Wouters; Michael Baumann; Philippe Lambin
Journal:  Radiother Oncol       Date:  2009-07-15       Impact factor: 6.280

10.  Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.

Authors:  Quynh-Thu Le; Christina Kong; Phillip W Lavori; Ken O'byrne; Janine T Erler; Xin Huang; Yijun Chen; Hongbin Cao; Robert Tibshirani; Nic Denko; Amato J Giaccia; Albert C Koong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-01       Impact factor: 7.038

View more
  27 in total

Review 1.  Molecular imaging-its current role in cancer.

Authors:  S McDermott; A Kilcoyne
Journal:  QJM       Date:  2015-08-07

2.  Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.

Authors:  Narges K Tafreshi; Mark C Lloyd; Joshua B Proemsey; Marilyn M Bui; Jongphil Kim; Robert J Gillies; David L Morse
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

3.  Dynamic oxygenation measurements using a phosphorescent coating within a mammary window chamber mouse model.

Authors:  Rachel Schafer; Arthur F Gmitro
Journal:  Biomed Opt Express       Date:  2015-01-29       Impact factor: 3.732

Review 4.  New frontiers in the design and synthesis of imaging probes for PET oncology: current challenges and future directions.

Authors:  Graham Smith; Laurence Carroll; Eric O Aboagye
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

Review 5.  Towards enhanced PET quantification in clinical oncology.

Authors:  Habib Zaidi; Nicolas Karakatsanis
Journal:  Br J Radiol       Date:  2017-11-22       Impact factor: 3.039

6.  Luminescent Probe Based Techniques for Hypoxia Imaging.

Authors:  Sana Sandhu; LeNaiya Kydd; Justyn Jaworski
Journal:  J Nanomed Res       Date:  2017-11-20

Review 7.  Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques.

Authors:  Sonja Stieb; Kendall Kiser; Lisanne van Dijk; Nadia Roxanne Livingstone; Hesham Elhalawani; Baher Elgohari; Brigid McDonald; Juan Ventura; Abdallah Sherif Radwan Mohamed; Clifton David Fuller
Journal:  Hematol Oncol Clin North Am       Date:  2019-10-31       Impact factor: 3.722

Review 8.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

Review 9.  Strategies for optimizing the response of cancer and normal tissues to radiation.

Authors:  Everett J Moding; Michael B Kastan; David G Kirsch
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

Review 10.  Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.

Authors:  Orit Jacobson; Xiaoyuan Chen
Journal:  Pharmacol Rev       Date:  2013-09-24       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.